Literature DB >> 31118162

Predictors of health-related quality of life in Parkinson's disease.

Greg D Kuhlman1, Joseph L Flanigan2, Scott A Sperling2, Matthew J Barrett2.   

Abstract

BACKGROUND: Health-related quality of life in Parkinson's disease may be affected by a wide range of motor and non-motor symptoms. Identifying which symptoms are significant predictors of health-related quality of life in Parkinson's disease prioritizes symptoms for treatment, therapeutic development, and clinical outcomes.
OBJECTIVES: To determine predictors of health-related quality of life in patients with Parkinson's disease.
METHODS: We recruited 102 subjects into a prospective study to investigate neuropsychiatric symptoms in Parkinson's disease. Health-related quality of life was measured with the 39-item Parkinson's Disease Questionnaire. Subjects completed the Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts I-IV as well as validated scales to assess anxiety, depression, apathy, cognition, psychosis, impulsive-compulsive disorder, autonomic dysfunction, sleep quality, excessive daytime sleepiness, and rapid eye movement sleep behavior disorder. We used univariate analyses to select clinical predictors to construct a multivariate regression model to determine which predictors were independently associated with worse health-related quality of life.
RESULTS: In a multivariate linear regression model adjusted for age and gender, higher scores for the International Parkinson and Movement Disorder Society Unified Parkinson's Disease Rating Scale part II as well more severe symptoms of depression, anxiety, apathy, and excessive daytime sleepiness were associated with worse health-related quality of life. The model explained 78% of the variance of health-related quality of life, and the non-motor symptoms explained 49% of the variance.
CONCLUSIONS: Anxiety, depression, excessive daytime sleepiness, apathy, and impairment in activities of daily living related to motor symptoms were independently associated with worse health-related quality of life.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Non-motor symptoms; Parkinson's disease; Predictors; Quality of life

Mesh:

Year:  2019        PMID: 31118162     DOI: 10.1016/j.parkreldis.2019.05.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

Review 1.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

2.  Predictors of anxiety in Parkinson's disease: results from a 3-year longitudinal cohort study.

Authors:  Jessie S Gibson; Joseph L Flanigan; James T Patrie; W Alex Dalrymple; Madaline B Harrison
Journal:  Neurol Sci       Date:  2022-10-11       Impact factor: 3.830

3.  Determinants of Quality of Life According to Cognitive Status in Parkinson's Disease.

Authors:  Yun Fan; Xiaoniu Liang; Linlin Han; Yan Shen; Bo Shen; Chen Chen; Yimin Sun; Jian Wang; Yilin Tang
Journal:  Front Aging Neurosci       Date:  2020-08-20       Impact factor: 5.750

4.  The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Authors:  Nicol G M Oonk; Kris L L Movig; Job van der Palen; Henk-Willem Nijmeijer; Mirjam E van Kesteren; Lucille D A Dorresteijn
Journal:  Clin Drug Investig       Date:  2021-08-10       Impact factor: 2.859

Review 5.  Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.

Authors:  Vanessa Raeder; Iro Boura; Valentina Leta; Peter Jenner; Heinz Reichmann; Claudia Trenkwalder; Lisa Klingelhoefer; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2021-02-09       Impact factor: 5.749

6.  Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.

Authors:  Nobutaka Hattori; Atsushi Takeda; Yuki Hanya; Tadayuki Kitagawa; Masaki Arai; Yoshihiko Furusawa; Hideki Mochizuki; Masahiro Nagai; Ryosuke Takahashi
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

7.  Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study.

Authors:  Bruna Meira; Bertrand Degos; Elise Corsetti; Mohamed Doulazmi; Emeline Berthelot; Clara Virbel-Fleischman; Pauline Dodet; Aurélie Méneret; Louise-Laure Mariani; Cécile Delorme; Florence Cormier-Dequaire; David Bendetowicz; Nicolas Villain; Clément Tarrano; Lise Mantisi; Hélène Letrillart; Céline Louapre; Eavan McGovern; Yulia Worbe; David Grabli; Marie Vidailhet; Elodie Hainque; Emmanuel Roze
Journal:  NPJ Parkinsons Dis       Date:  2021-06-11

8.  Validation of an Individualized Measure of Quality of Life, Patient Generated Index, for Use with People with Parkinson's Disease.

Authors:  Ayse Kuspinar; Kedar K V Mate; Anne-Louise Lafontaine; Nancy Mayo
Journal:  Neurol Res Int       Date:  2020-03-30

Review 9.  Obstructive Sleep Apnea in Neurodegenerative Disorders: Current Evidence in Support of Benefit from Sleep Apnea Treatment.

Authors:  Annie C Lajoie; Anne-Louise Lafontaine; R John Kimoff; Marta Kaminska
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

10.  Predictive Model of Quality of Life in Patients with Parkinson's Disease.

Authors:  Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Marta Carolina Ruiz-Grao; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.